Bicarbonate

Bicarbonate

SCHEMBL17199718

CCCCCCCCCC[N+](C)(C)C.O=C(O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 8/20 0.75
APAF1 O14727 1/20 0.68
HSP90AA1 P07900 1/20 0.68
RAD52 P43351 1/20 0.68
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
APEX1 P27695 3/20 0.55
NFKB1 P19838 2/20 0.55
KDM4E B2RXH2 2/20 0.55
ACHE P22303 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
PMP22 Q01453 2/20 0.55
LMNA P02545 2/20 0.55
HSD17B10 Q99714 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
TSHR P16473 1/20 0.55
RAB9A P51151 1/20 0.55
NPSR1 Q6W5P4 1/20 0.52
HTT P42858 1/20 0.52
SLC22A1 O15245 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL27839094 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL28072724 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL27856897 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL27990803 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL5157446 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL28963225 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL9724758 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Cetrimonium SCHEMBL9739307 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL17199724 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL26109031 1.00 DNM1 (0.75) DNM1APAF1HSP90AA1RAD52MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2937369-B1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST TOSOH CORP (JP) 2020-11-11 EP claimed
US-20150344727-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT AND USE THEREOF TOSOH CORPORATION (JP) 2015-12-03 US claimed
EP-2937369-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST Tosoh Corporation (JP) 2015-10-28 EP claimed
CN-117157249-B Cage silicate and method for producing same 日产化学株式会社 2024-08-13 CN disclosed
EP-4363080-A1 ABSORBENT AQUEOUS COMPOSITION CONTAINING A BASE AND AN AZOLE FOR SEPARATING CARBON DIOXIDE FROM A GASEOUS EFFLUENT IFP Energies nouvelles (FR) 2024-05-08 EP disclosed
CN-117597185-A Aqueous absorbent composition containing alkali and oxazole for separating carbon dioxide from gaseous effluent IFP 新能源公司 2024-02-23 CN disclosed
WO-2023238500-A1 TREATMENT AGENT FOR CARBON FIBER PRECURSOR, AND CARBON FIBER PRECURSOR 竹本油脂株式会社 2023-12-14 WO disclosed
CN-117157249-A Cage silicate and method for producing same 日产化学株式会社 2023-12-01 CN disclosed
EP-2937369-B1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST TOSOH CORP (JP) 2020-11-11 EP disclosed
CN-105829375-B Allophanate-isocyanurateing catalyst, polyisocyanate composition, method for producing the composition, and two-component coating composition 东曹株式会社 2019-09-20 CN disclosed
US-20150344727-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT AND USE THEREOF TOSOH CORPORATION (JP) 2015-12-03 US disclosed
EP-2937369-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST Tosoh Corporation (JP) 2015-10-28 EP disclosed
CN-104334721-A Polysilicate-polysilicone enzyme immobilization material AKERMIN INC 2015-02-04 CN disclosed
CN-102232004-A Process for accelerated capture of carbon dioxide AKERMIN INC 2011-11-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344727-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT AND USE THEREOF CA2, KCNMB1, BET1 DNM1 780/4885APAF1 2421/4885HSP90AA1 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.